Expiring the FOA
Find Funding Opportunities
NIH Extramural Response to Natural Disasters and Other Emergencies
In emergency situations, the NIH’s immediate concern is for the health and safety of people and animals in the programs we oversee. Visit the NIH Extramural Response to Natural Disasters and Other Emergencies web page for biomedical research community resources, including NIH Guide Notices and other information of particular relevance to investigators and their institutions, links to web pages listing NIH’s response to certain major events (past and present); and links to similar web sites from other Federal agencies.
COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements
All NINDS-related notices of funding opportunities (NOFOs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed. Search the Closed Opportunities tab to find expired opportunities. Search the Notices tab to find all Notices.
Learn more about award types and program directors and managers.
NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!
For more focused results add quotes to indicate parameters. Example format: "search term".
Notice of Early Expiration of RFA-NS-21-022 "Translational Neural Devices (U44 Clinical Trial Optional)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-23-055
Tuesday, December 20, 2022
Notice Type: NOT
Notice of NINDS Participation in RFA-TR-22-030: "Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-23-052
Thursday, December 8, 2022
Notice Type: NOT
The Purpose of this Notice is to inform potential applicants that the National Institute of Neurological Disorders and Stroke (NINDS) is participating, effective immediately, in RFA-TR-22-030 "Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trials Not Allowed).
Notice of Change to Eligibility Information for RFA-NS-22-050 "HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-23-051
Wednesday, December 7, 2022
Notice Type: NOT
The purpose of this notice is to inform applicants of a change to the Eligibility Information for RFA-Ns-22-050 "HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional)". The Funding Opportunity Announcement (FOA) has been modified to show that "foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Notice of NINDS Specific Interest in AD/ADRD for PAS-22-196 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-23-049
Thursday, December 1, 2022
Notice Type: NOT
The purpose of this notice is to add NINDS-specific research interests in PAS-22-196 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)".
Notice of NINDS Specific Interest in AD/ADRD for PAS-22-197 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-23-050
Thursday, December 1, 2022
Notice Type: NOT
The purpose of this notice is to add NINDS-specific research interests in PAS-22-197 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)".
Notice of Change to the Key Dates for PAR-20-049 "NINDS Postdoctoral Mentored Career Development Award (K01 - No Independent Clinical Trial Allowed)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-23-044
Friday, November 25, 2022
Notice Type: NOT
The purpose of this notice is to inform interested applicants of a change to the Key Dates for PAR-20-049 "NINDS Postdoctoral Mentored Career Development Award (K01 - No Independent Clinical Trial Allowed)". This Funding Opportunity Announcement (FOA) has been extended by one additional council round.
Notice of Change to the Key Dates for PAR-20-050 "NINDS Postdoctoral Mentored Career Development Award (K01 - Clinical Trial Required)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-23-045
Friday, November 25, 2022
Notice Type: NOT
The purpose of this notice is to inform interested applicants of a change to the Key Dates for PAR-20-050 "NINDS Postdoctoral Mentored Career Development Award (K01 - Clinical Trial Required)". This Funding Opportunity Announcement (FOA) has been extended by one additional council round.
Notice of Correction to Eligibility Criteria for RFA-NS-22-011 "BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-23-047
Monday, November 21, 2022
Notice Type: NOT
The purpose of this notice is to inform applicants of a correction to the Eligibility Information for RFA-NS-22-011 "BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed). For this Funding Opportunity Announcement (FOA), "Section III. Eligibility Information" has been corrected to allow intramural participation. This is consistent with the intramural participation language in "Section IV. Application and Submission Information, 7. Other Submission Requirements and Information".
Request for Information: Soliciting Public Comment on Draft Amyotrophic Lateral Sclerosis (ALS) Strategic Plan
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-23-041
Monday, November 14, 2022
Notice Type: NOT
The purpose of this time-sensitive Request for Information (RFI) is to seek input on the Draft ALS Strategic Plan from people living with amyotrophic lateral sclerosis (ALS), families, caregivers, people with genetic risk of ALS, advocates, scientists, clinicians, and the broader community.
Notice of Change to Key Dates and Review Locus for RFA-NS-19-043 BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-23-039
Thursday, November 10, 2022
Notice Type: NOT
The purpose of this notice is to inform applicants of a change to the Key dates and review locus for RFA-NS-19-043 "BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)". This Funding Opportunity Announcement (FOA) has been extended by one additional council round.